Anita Brikman: There Are Countless More Individuals Who Would Benefit from Access to Plasma-Derived Medicines
AnitaĀ Brikman, President and CEO of the Plasma Protein Therapeutics Association (PPTA), shared onĀ LinkedIn:
āAs International Plasma Awareness Week comes to a close, Iām grateful to all who supported the incredible efforts to recognize the lifesaving power of plasma and plasma donors. It was truly moving to see how Plasma Powers Possibility for so many around the globe.
But it is also clear that our mission doesnāt stop here. There are countless more individuals who would benefit from access to plasma-derived medicines, especially those in lower and middle income countries where the availability of treatment for rare diseases is limited at best.
The Plasma Protein Therapeutics Association (PPTA) efforts around awareness, advocacy, and access will continue on a daily basis. Because in reality, every week should be an awareness week filled with opportunities to reach out and educate. Pictured below are some of our awareness and activities from IPAW2025 including a powerful patient webinar, a Brussels panel on the Critical Medicines Act, a moving patient and donor meeting with GBS|CIDP Foundation International, and just one of the many patient testimonials we received over the last few days.
Next week, the momentum continues at the Plasma Protein Forum, where industry leaders, health care providers, and patient advocates will come together to advance innovation and address timely issues that impact the entire plasma community.
Thereās still time to register, and I hope to see many of you there.
Visit the forum for more details on next weekās gathering.ā
Stay updated withĀ Hemostasis Today.
-
Apr 11, 2026, 13:51David McIntosh: Vital Plasma Derived Medicines – The Anomalous UK Scene
-
Apr 11, 2026, 13:47Samrawit Terefe: O Negative Blood Is the Universal Donor With Extreme Scarcity
-
Apr 11, 2026, 13:39Dheeraj Garg: Rethinking Cardiovascular Disease – A Cardiologistās Perspective
-
Apr 11, 2026, 13:37Kushal Bhatia: Is The 4.5-Hour Thrombolysis Window Officially Outdated?
-
Apr 11, 2026, 13:35William Aird: Why Did Mammalian Red Blood Cells Give Up Their Nucleus?
-
Apr 11, 2026, 13:30Ken Kuang: Gravity Is Constant, But Your Vein Health Doesnāt Have to Be
-
Apr 11, 2026, 13:21Mascha Kern: Measuring Genderās Role in Stroke and Migraine
-
Apr 11, 2026, 13:10Danique Steeghs: Key Findings from a Microfluidic Chemiluminescent Thrombin Generation Assay
-
Apr 11, 2026, 13:06Shanvi Mahi: A Validated Tool to Explore Lived Experiences After Stroke Rehabilitation